Lifestyle interventions remain the foundation, including: Research into the use of GLP-1 receptor agonists in younger children is ongoing, including long-term effects
Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma
Both medications cause similar gastrointestinal side effects, including nausea, constipation, diarrhea, and vomiting
Let us partner with you on the path to a healthier, happier you
GLP-1 receptor activation exerts profound systemic effects that indirectly benefit hepatic steatosis and MASH through multiple complementary mechanisms
Most retatrutide-related diarrhea is mild to moderate, peaks during dose escalation, and resolves within 8 to 12 weeks for the majority of participants